Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mar a Jos Torres
Observed names:
M. Torres,
María José Torres
Institutions:
Hospital Regional Universitario de Málaga,
Andalusian Centre for Nanomedicine and Biotechnology,
Instituto de Investigación Biomédica de Málaga,
Universidad de Málaga
Observed institutions:
Hospital Regional Universitario de Málaga,
Andalusian Centre for Nanomedicine and Biotechnology,
Instituto de Investigación Biomédica de Málaga,
Universidad de Málaga
ORCID:
0000-0001-5228-471X
Observed ORCID:
0000-0001-5228-471X
OpenAlex ID:
A5062913035
Practice Parameters for Diagnosing and Managing Iodinated Contrast Media Hypersensitivity
2020
·
María José Torres
, Axel Trautmann
, et al.
·
31
PDF
Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy
2026
·
Marina Labella
, Rafael Nuñez
, et al.
·
Allergy
·
7
PDF
Group 2 innate lymphoid cells are key in lipid transfer protein allergy pathogenesis
2024
·
Francisca Palomares
, Natalia Pérez-Sánchez
, et al.
·
Frontiers in Immunology
·
6
PDF
A compendium answering over 140 questions on COVID-19 and SARS-CoV-2
2020
·
CARMEN RIGGIONI
, Pasquale Comberiati
, et al.
·
4
PDF
Basophil activation test as an useful predictive tool for assessing effective tolerant response to Pru p 3 sublingual immunotherapy in patients with lipid transfer protein allergy.
2025
·
María del Carmen Martín Astorga
, Anyith Cruz-Amaya
, et al.
·
Journal of Allergy and Clinical Immunology
·
1
PDF
Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactions
2023
·
A. Soria
, M. Labella
, et al.
·
Revue française d'allergologie
PDF
Hypersensitivity reactions to arylpropionic acid derivatives: different drugs inducing different response patterns
2020
·
Inmaculada Doña
, Natalia Pérez-Sánchez
, et al.
Show more works
View as search
Works count:
7
Citation count:
49
H-index:
4
I10-index:
1
Year
Topic
Type